Pulmonary TB Flashcards

1
Q

PULMONARY TUBERCULOSIS

A

• Estimated 1/3 of world population infected with TB; Majority of cases in Africa and Asia (India
and China); Coinfection with HIV remains a major problem because of heavy healthy burden and growing incidence of drug resistant strains and high mortality of both disease
• Responsible for 1.4 million deaths in 2010; 25% of which are HIV coinfected individuals
• Four main Mycobacteria species together called Mycobacterium tuberculosis complex (MTb);
Mycobacterium tuberculosis, bovis, africanum and microti
o Obligate aerobes and facultative intracellular pathogens; infects mononuclear
phagocytes (e.g. Macrophages); Slow growing generation time of 12-18 hours
o High lipid content of cell wall; Relatively impermeable, stains weakly with Gram;
When stained with Dye and Phenol, and washed with Acid organic solvents they resist
decolourisation = Acid-fast Bacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

At Risk Population

A

Immigrants from affected areas, Elderly and Immunosuppressed,
Diabetics, Alcoholics and Homeless`

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathogenesis of Tuberculosis

A

• Airborne infection spread via respiratory droplets; Only a small number required to develop
infection but not all infected develop active disease
• Development of disease depends on many factors including contact with high-risk groups,
immune deficiency (E.g. HIV, Immunosuppressant therapy, CKD and DM, Malnutrition)
• Primary Tuberculosis – First infection with MTb; Alveolar macrophages ingest bacteria and
proliferation occurs intracellularly resulting in release of Neutrophil Chemokines and
Cytokines; Inflammatory infiltrate reaches Lungs and Hilar Lymph Nodes
• Macrophages present antigen to T cells to develop Cell-mediated Immunity, resulting in
delayed Hypersensitivity-like reaction causing Tissue Necrosis and Granuloma formation
• Granuloma consists of central Necrosis (Caseation) surrounded by Macrophage-derived
Epithelioid cells and multinucleated Langhans’ Giant Cells; Lymphocytes also present
o Initial focus of disease is termed Ghon focus; seen on CXR as small Calcified nodule
often within midzone near the Hilum; Focus can also develop within regional draining
lymph node (Primary complex of Ranke)

• Some caseated areas heal completely while many become calcified; Some Calcified nodules
contain bacteria which are contained by the Immune System and Hypoxic, Acidic environment
of the Granuloma, and are capable of lying dormant for years
o Upon initial contact <5% of people develop active disease; 10% within 1yr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Latent Infection

A
Bacilli present in Ghon focus
Sputum and culture negative
Tuberculin positive
CXR normal (small calcified Ghon focus)
Asymptomatic
Not infectious to others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Active Disease

A

Bacilli in tissues/secretions
MTb cultured from sputum and infected tissue
Tuberculin usually positive and can ulcerate
Consolidation, Cavitation, Pulmonary Effusion
Night sweats, Fevers, Weight loss, Cough
Infectious if bacilli present in Sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Latent Tuberculosis

A

Immune system contains the infection in majority of people and patient
develops Cell-mediated Immune memory to bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Reactivation Tuberculosis

A

Majority of TB cases due to Reactivation of Latent infection;
Usually many years from initial contact; HIV patients with newly acquired TB is also common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Presentation of Tuberculosis

A

Pulmonary, Pleural, Laryngeal, Miliary, CNS,
and Lymph Node presentations in either
primary or reactivation TB; Extrapulmonary
involvement far less common, usually seen
only in regions of high endemicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pulmonary TB

A
Productive cough,
Haemoptysis with systemic symptoms
of Weight Loss, Fevers, Sweats (End of
day and throughout night); Laryngeal
involvement results in Hoarseness and
severe Cough; Pleura involvement
results in Pleuritic pain
▪ CXR – Consolidation ±
Cavitation, Pleural Effusion or
Mediastinum thickening/widening due to Hilar/Paratracheal Adenopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lymph Node TB

A

– Extrathoracic nodes more commonly involved than
Intrathoracic/Mediastinal; presents as firm, non-tender enlargement of Cervical and
Supraclavicular nodes; Node becomes necrotic centrally and can liquefy and become
fluctuant if peripheral
▪ Overlying skin indurated; Sinus tract formation with purulent discharge but
characteristically no erythema occurs (Cold Abscess Formation)
▪ CT imaging reveals necrotic centre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Miliary TB

A
Haematogenous spread
to multiple sites including CNS (20% of
cases); Systemic upset with
Respiratory symptoms in majority;
Microabscesses in Liver and Spleen
resulting in deranged LFTs or
Cholestasis with GI symptoms
▪ CXR – Multiple nodules that
appear like Millet seeds
o Other forms of TB include
Gastrointestinal, TB of Bone/Spine,
Skin, Pericardium and CNS TB
• Substantial effort to obtain tissue/fluid for
MCS; Tissue samples for histopathology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Microbiological Diagnosis of Tuberculosis

A

• Auramine-Rhodamine Fluorescence microscopy (Bacilli appears yellow-orange) staining more
sensitive but less specific than Ziehl-Neelsen
• Liquid/Broth culture in addition to solid media (Lowenstein-Jensen or Middlebrook); Liquid
culture in the presence of anti-Mycobacterial drugs establishes drug sensitivity in 3 weeks
• Microscope observation of Drug Sensitivity (MODS) assay compares growth of wells in liquid
media with different drugs; Inexpensive but labour intensive and operator dependent
• Nucleic Acid Amplification – Useful for differentiating MTb from Non-TB Mycobacteria (NTM);
Also detects dead organisms; Useful for CNS TB and identifying drug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Management of Tuberculosis

A

• Fully sensitive TB patients requires 6 months; CNS TB requires at least 12 months
• Corticosteroids for CNS and Pericardial Disease to reduce long term complications
• Direct Observed Therapy (DOT) – Treatment supervised by healthcare professional or family
member; Majority of relapsed disease/treatment failure due to lack of adherence,
interrupted treatment or incorrect treatment
o Dosing frequency may be reduced to 3 times a week; Success rate comparable to
standard unsupervised daily therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug Regimen for Active Tuberculosis

A
Initial 2 months
Rifampicin (inhibit DNA dependent RNA polymerase)
Isoniazid (against bacterial cell wall)
Ethambutol (against bacterial cell wall)
Pyrazinamide (only used in combination, lowers bacterial pH)
Further 4 months
10 months + Steroids if CNS
Rifampicin
Isoniazid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rifampicin

A

Induction of Liver Enzymes (concomitant drugs less effective); Stopped if
Bilirubin elevated or Transferases are >3× elevated; Stains body secretions pink
o Oral Contraception not effective so alternative birth control required
o Rifabutin – Used for prophylaxis against MAI in HIV patients with CD4 <200/mm3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Isoniazid

A

Polyneuropathy due to B6 deficiency rarely; Customary to prescribe Pyridoxine
10mg daily for prevention; Allergic reactions (Rash, Fever and Hepatitis in <1% of cases)

17
Q

Pyrazinamide

A

Hepatic toxicity; Reduces renal excretion of urate, precipitate Gout

18
Q

Ethambutol

A

– Dose related Optic Retrobulbar Neuritis (colour blindness for green, reduction
in acuity and central scotoma) more common at doses 25mg/kg

19
Q

Streptomycin

A

Irreversible Vestibular Nerve damage; Allergic reactions more common than
to Rifampicin, Isoniazid or Pyrazinamide; Used for MDR-TB

20
Q

Drug Resistance

A
  • MDR-TB – Resistance to both Rifampicin and Isoniazid
  • XDR-TB – High Resistance to Rifampicin, Isoniazid, Fluoroquinolones and at least one injectable agent (e.g. Aminoglycosides)
21
Q

HIV-Coinfection

A

Increased Morbidity and Mortality; Drug interactions and intolerability,
Increased risk of Toxicity and higher incidence of Resistance

22
Q

Chronic Kidney Disease

A

Risk factor for reactivation due to relative immune paresis; Patients
undergoing Renal Transplant need to be screened for Latent TB; CKD complicates drug
therapy and drug monitoring should be used

23
Q

Non-Tuberculous Mycobacteria (NTM)

A

Occur in soil and water, not usually pathogenic;
Opportunistic to immunosuppressed patients; Treatment if compatible clinical picture and
isolated organism from invasive sample or in more than one sputum at different times
o COPD, Bronchiectasis, Cystic Fibrosis, Previous TB, HIV infection etc
o Includes Mycobacterium Avium Intracellulare Complex (MAC) associated with HIV
patients with CD4 count <200/mm3

24
Q

Latent Tuberculosis

A
• Demonstrates immune memory to
Mycobacterial proteins
• Tuberculin Skin Test (Mantoux) –
Delayed Hypersensitivity 48-72hrs after
intradermal Purified Protein Derivative;
>6mm in non-vaccinated, >15mm in
BCG-vaccinated; False negative in
immunosuppressed, Sarcoidosis, and
Age/Disease, false positive due to NTM infection or BCG
25
Q

Mantoux Testing and IGRA

A

• Injection of purified protein derivative Tuberculin (extracted from TB bacteria);
o Standard dose, injected intradermally and read 48 – 72hrs later; Immune response
expected in patients exposed to bacteria (either through infection or BCG)
o Measuring diameter of induration in millimetres; Erythema is ignored
• 5mm or more induration considered positive if recent contacts, previous TB infection or
immunosuppressed
• 10mm or more consider positive if from high-incidence areas, patients at high risk of TB,
• 15mm or more if no known risk factors for TB
• If previous BCG – Consider IGRA to interpret positive Mantoux tests
• Interferon-gamma Release Assays – Detect T cell secretion of IFN-γ following exposure to TB
specific antigens; Measured through testing in-vitro from extracted whole-blood
o Does not differentiate Latent from Active Infection; Highly specific compared to TST
with better/similar sensitivity

26
Q

BCG Vaccination

A

• Live Attenuated Vaccine derived from Mycobacterium bovis which has lost virulence; Variable
efficacy shown to reduce risk of disseminated and CNS TB in babies and children
• Safety concerns in babies with HIV; Efficacy in adults very variable

27
Q

TB Notification

A

• Notification – All forms required to notify if M TB Complex; If culture negative, notify if
clinically symptomatic and treated with full course of Anti TB drugs
o Enhanced TB Surveillance System (ETS), or London TB Register online mainly
o Notify within 3 working days or making/suspecting; Should not be delayed if full case
information or laboratory confirmation not yet available (can be updated)
o Urgent verbal notification must be followed up with ETS/LTBR online form
o Some trusts engage nurses, microbiology or pathology to notify

28
Q

Contact Tracing

A

• Diagnosing physician should inform relevant colleagues so contact tracing can be assessed;
Should not be delayed until notification
o Offer screening of close contacts of any person with Pulmonary or Laryngeal TB
o Assess symptomatic close contacts for active TB
• Asymptomatic close contacts <65yrs – Consider standard testing for Latent TB, or treatment
once active TB has been ruled out if previous unvaccinated and Mantoux negative
o >65yrs – Consider CXR and subsequent further investigation for active TB
• Do not routinely assess Social Contacts (which include most workplace)

29
Q

Presentations of Non-Pulmonary Tuberculosis

A

Next common site is LN TB – Extrathoracic nodes more common vs Intrathoracic and
Mediastinal; Usually firm, non-tender enlargement of Cervical or Supraclavicular LN
o Necrotic centre, can liquefy and become fluctuant
o Underlying skin commonly indurated, or sinus tract formation with purulent
discharge (characteristically without erythema =Cold Abscess)
Other sites include Skin and Pericardial TB

30
Q

Gastrointestinal TB

A
Abdominal Pain, Weight Loss, Fever, Night Sweats, Ileocaecal most
commonly affected (RIF pain or palpable mass)
o 1/3 present with intestinal obstruction, or generalised peritonitis
31
Q

TB Bone and Spine

A

1%; Primary disease in children or Haematogenous spread in adults;
Invasion of Synovium or IV disc; Hip, Knee and Spine commonly, Immunosuppressed patients

32
Q

Miliary TB

A

Haematogenous spread; 20% involves CNS; Presents with Systemic Upset;
Respiratory Symptoms in majority
o Also involves GI Tract (Liver and Splenic Micro-abscess) resulting in deranged LFTs,
Cholestatic picture and GI symptoms

33
Q

CNS TB

A

Vague ill health before history of Meningeal irritation – Fever, Neck Stiffness,
Seizures; Focal Neurological deficit, Behavioural changes, Altered mental state
o LP – Low relative glucose to plasma, Lymphocytosis (C/f Neutrophilia and
Granulocytosis in other bacterial infections), High protein